Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
Dermatol Ther ; 35(6): e15464, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-35306720

RESUMEN

Generalized erythrodermic psoriasis (GEP) is a rare and potentially life-threatening variant of psoriasis. Possible triggers that have been identified to date include poorly controlled psoriasis, medications, abrupt discontinuation of anti-psoriatic treatment, and underlying systemic illnesses. However, vaccines have rarely been reported to exacerbate GEP. Herein, we report two unique cases with GEP exacerbated following a dose of the BNT162b2 mRNA vaccine for COVID-19 (as their second dose, the first being the mRNA-1273 vaccine). Based on our observations and a literature review, vaccination was considered the most likely trigger of GEP due to the close temporal relationship between the second vaccination and the onset of GEP.


Asunto(s)
Vacuna BNT162 , COVID-19 , Psoriasis , Vacuna nCoV-2019 mRNA-1273 , Vacuna BNT162/efectos adversos , COVID-19/prevención & control , Humanos , Psoriasis/inducido químicamente , SARS-CoV-2 , Vacunación/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA